HAVN Life Sciences

About:

Biotechnology company engaged in the extraction and distribution of psychoactive compounds, and developing natural health care products.

Website: https://havnlife.com/

Top Investors: Alpha Blue Ocean

Description:

HAVN Life Sciences is a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs, the development of natural health products, and innovative therapies to support central nervous system health and enhance the capabilities of the mind.

Total Funding Amount:

22.5M CAD

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Vancouver, British Columbia, Canada

Founded Date:

2020-01-01

Founders:

Alexzander Samuelsson, Barinder Rasode

Number of Employees:

1-10

Last Funding Date:

2022-07-21

IPO Status:

Public

Industries:

© 2025 bioDAO.ai